Katana VentraIP

Acute radiation syndrome

Acute radiation syndrome (ARS), also known as radiation sickness or radiation poisoning, is a collection of health effects that are caused by being exposed to high amounts of ionizing radiation in a short period of time.[1] Symptoms can start within an hour of exposure, and can last for several months.[1][3][5] Early symptoms are usually nausea, vomiting and loss of appetite.[1] In the following hours or weeks, initial symptoms may appear to improve, before the development of additional symptoms, after which either recovery or death follow.[1]

"Radiation poisoning" redirects here. For other uses, see Radiation poisoning (disambiguation).

Acute radiation syndrome

Radiation poisoning, radiation sickness, radiation toxicity

Early: Nausea, vomiting, skin burns, loss of appetite[1]
Later: Infections, bleeding, dehydration, confusion[1]

Within days[1]

Bone marrow syndrome, gastrointestinal syndrome, neurovascular syndrome[1][3]

Large amounts of ionizing radiation over a short period of time[1]

Based on history of exposure and symptoms[4]

Depends on the exposure dose[4]

Rare[3]

ARS involves a total dose of greater than 0.7 Gy (70 rad), that generally occurs from a source outside the body, delivered within a few minutes.[1] Sources of such radiation can occur accidentally or intentionally.[6] They may involve nuclear reactors, cyclotrons, certain devices used in cancer therapy, nuclear weapons, or radiological weapons.[4] It is generally divided into three types: bone marrow, gastrointestinal, and neurovascular syndrome, with bone marrow syndrome occurring at 0.7 to 10 Gy, and neurovascular syndrome occurring at doses that exceed 50 Gy.[1][3] The cells that are most affected are generally those that are rapidly dividing.[3] At high doses, this causes DNA damage that may be irreparable.[4] Diagnosis is based on a history of exposure and symptoms.[4] Repeated complete blood counts (CBCs) can indicate the severity of exposure.[1]


Treatment of ARS is generally supportive care. This may include blood transfusions, antibiotics, colony-stimulating factors, or stem cell transplant.[3] Radioactive material remaining on the skin or in the stomach should be removed. If radioiodine was inhaled or ingested, potassium iodide is recommended. Complications such as leukemia and other cancers among those who survive are managed as usual. Short term outcomes depend on the dose exposure.[4]


ARS is generally rare.[3] A single event can affect a large number of people,[7] as happened in the atomic bombings of Hiroshima and Nagasaki and the Chernobyl nuclear power plant disaster.[1] ARS differs from chronic radiation syndrome, which occurs following prolonged exposures to relatively low doses of radiation.[8][9]

Diagnosis[edit]

Diagnosis is typically made based on a history of significant radiation exposure and suitable clinical findings.[3] An absolute lymphocyte count can give a rough estimate of radiation exposure.[3] Time from exposure to vomiting can also give estimates of exposure levels if they are less than 10 Gy (1000 rad).[3]

Other animals[edit]

Thousands of scientific experiments have been performed to study ARS in animals. There is a simple guide for predicting survival and death in mammals, including humans, following the acute effects of inhaling radioactive particles.[70]

. U.S. Radiation Emergency Assistance Center Training Site REACts. Archived from the original on 2023-05-05.

"Emergency preparedness and subject matter expertise on the medical management of radiation incidents"

. U.S. Centers for Disease Control and Prevention. Archived from the original on 16 July 2006. Retrieved 22 July 2006.

"Fact sheet on Acute Radiation Syndrome"

(PDF). International Atomic Energy Agency. 2001. – A well documented account of the biological effects of a criticality accident.

"The criticality accident in Sarov"

. Archived from the original on 2015-03-03. Retrieved 2011-07-01.

"Armed Forces Radiobiology Research Institute"

More information on bone marrow shielding can be found in the article: Waterman, Gideon; Kase, Kenneth; Orion, Itzhak; Broisman, Andrey; Milstein, Oren (September 2017). "Selective Shielding of Bone Marrow: An Approach to Protecting Humans from External Gamma Radiation". Health Physics. 113 (3): 195–208. doi:10.1097/HP.0000000000000688. PMID 28749810. S2CID 3300412., or in the Organisation for Economic Co-operation and Development (OECD) and the Nuclear Energy Agency (NEA)'s 2015 report: "Occupational Radiation Protection in Severe Accident Management"

Health Physics Radiation Safety Journal